| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer-clia
1 company
Leite John is a Chief Commercial Officer-clia at VERACYTE, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 1,278 | $47.51 | $60,717.78 | -1.5% | -23.5% | - | |
| Nov 25, 2025 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 2,808 | $50.00 | $140,400.00 | -3.2% | -27.6% | - | |
| Oct 1, 2025 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 2,539 | $35.00 | $88,865.00 | -2.8% | +16.8% | - | |
| Jun 4, 2025 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 2,809 | $27.20 | $76,409.86 | -2.9% | +10.3% | - | |
| Mar 7, 2025 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 7,411 | $31.66 | $234,629.55 | -3.5% | -15.7% | +5.7% | |
| Feb 27, 2025 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 5,746 | $33.84 | $194,444.64 | -6.8% | -21.0% | +8.0% | |
| Dec 3, 2024 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 1,050 | $43.25 | $45,407.88 | -1.4% | -23.1% | +9.4% | |
| Sep 4, 2024 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 5,479 | $29.78 | $163,159.14 | -6.7% | +47.7% | +6.7% | |
| Jul 16, 2024 | VCYT Veracyte, Inc. | Chief Commercial Officer-clia | Sell | 1,277 | $25.00 | $31,925.00 | -1.5% | +32.7% | -1.5% |